Lymphoma

Latest News

Completion of the phase 1 first-in-human trial revealed that iPSC-derived CAR natural killer cell therapy has potential for development across oncology.
FT596 Shows Favorable Tolerability, Response Rate in B-Cell Lymphoma

February 7th 2025

Completion of the phase 1 first-in-human trial revealed that iPSC-derived CAR natural killer cell therapy has potential for development across oncology.

MZL Workshop Paves the Way for Better Treatment Options
MZL Workshop Paves the Way for Better Treatment Options

February 7th 2025

MZL Expert Insights Summit Sponsored by the Lymphoma Research Foundation
MZL Expert Insights Summit Sponsored by the Lymphoma Research Foundation

February 6th 2025

CHMP Recommends Liso-cel in Pretreated R/R Follicular Lymphoma for Approval
CHMP Recommends Liso-cel in Pretreated R/R Follicular Lymphoma for Approval

January 31st 2025

CD19-directed CAR T therapy for T-cell/histiocyte-rich large B-cell lymphoma
CD19-directed CAR T therapy for T-cell/histiocyte-rich large B-cell lymphoma

January 28th 2025

More News